Administration of Biosimilar Insulin Analogs: Role of Devices-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Administration of Biosimilar Insulin Analogs: Role of Devices

Published:2017-02 Issue:2 Volume:19 Page:79-84
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Heinemann Lutz¹,Fritz Ingo²,Khatami Hootan³,Edelman Steven V.⁴

Affiliation:

1. Science & Co., Düsseldorf, Germany.

2. Device Development, Sanofi, Frankfurt, Germany.

3. Escala Therapeutics, a subsidiary of Fortress Biotech, New York, New York.

4. Division of Endocrinology and Metabolism, University of California San Diego, San Diego, California.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2016.0263

Reference19 articles.

1. The Biosimilar Insulin Landscape: Current Developments

2. The new world of biosimilars: what diabetologists need to know about biosimilar insulins

3. An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins

4. Regulation of medical devices used in diabetology in Europe: Time for reform?

5. Reusable and Disposable Insulin Pens for the Treatment of Diabetes: Understanding the Global Differences in User Preference and an Evaluation of Inpatient Insulin Pen Use

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary;Clinical Pharmacology & Therapeutics;2022-11-04

2. Biosimilar insulin concepts;Journal of Diabetes;2022-03-28

3. Diabetes and Treatments;Obesity and Diabetes;2020

4. New Insulins, Biosimilars, and Insulin Therapy;Diabetes Technology & Therapeutics;2019-02

5. Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review;PLOS ONE;2018-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3